Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) hit a new 52-week low during trading on Wednesday . The company traded as low as $9.51 and last traded at $9.51, with a volume of 100 shares traded. The stock had previously closed at $9.79.
Ambu A/S Price Performance
The company’s fifty day moving average is $10.19 and its two-hundred day moving average is $11.87. The company has a quick ratio of 1.73, a current ratio of 2.92 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $2.23 billion, a price-to-earnings ratio of 33.96 and a beta of 0.98.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. The business had revenue of $246.39 million for the quarter. Ambu A/S had a return on equity of 8.03% and a net margin of 7.81%.
About Ambu A/S
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Further Reading
- Five stocks we like better than Ambu A/S
- Microsoft’s Xbox Problem Is Bigger Than a Console War
- Dave & Buster’s Q1 Miss Raises the Stakes for Its Turnaround Plan
- Flying Under the Radar: Lockheed Martin’s $2.8B Stealth Setup
- Bread’s Comeback Is Real—But Is the Easy Money Gone?
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
